Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Tools & Technology › PCR › Biocartis Submits Idylla Platform With Janssen Flu, RSV Test to FDA

Biocartis Submits Idylla Platform With Janssen Flu, RSV Test to FDA

Dec 22, 2016
|
staff reporter

NEW YORK (GenomeWeb) ­– Biocartis announced today that it has submitted its Idylla molecular diagnostics platform to the US Food and Drug Administration for 510(k) clearance, along with a respiratory panel from partner Janssen Diagnostics to detect influenza and respiratory syncytial virus using the Idylla platform.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Featured Webinar

COVID-19 Testing, Treatment and Future Outlook

Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

What's Popular?

In PCR

  1. BioGX, Bosch Healthcare Solutions Partner to Develop Point-of-Care Infectious Disease Tests

  2. Bio-Me Eyes PCR-Based Microbiome Profiling Technology for Future CDx

    Premium

  3. SpectronRx Coronavirus Test Gets FDA Emergency Use Authorization

  4. BioCore, SolGent, Seasun Get FDA Emergency Use Authorizations for Coronavirus Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.